Covid vaccination programme india16 january 2021 world’s Biggest covid-19 programme in india Covid vaccine information

covid-19 vaccines
Covid vaccination programme india16 january 2021 world's Biggest covid-19 programme in india Covid vaccine information

India has begun one of the world’s biggest covid -19 vaccination programmes ,the first major developing country roll out the vaccine,marking the beginning of an effort to immunise more than 1.3billion people.

The first dose FDA satatement on following the authorized dosing Schedules for covid-19 vaccine The avaible data continue to support the use of two specified dose of each authorized vaccine at specified interval.For Pfizer-bioNtech covid-19 vaccine ,the interval is 21 days between the first and second dose.

Two different mRNA vaccines have now show remarkable effectiveness COVID-19 disease in adult.as the first round of vaccine receive their second dose we,want to remind the public about the importance of receiving covid-19 vaccine according to how they been authorized by the FDA in order to safely receive the level of protection observed in the large randomized trials supporting their effectiveness.

covid-19 Virus

The first dose was administered to a health worker at all india institute of medical staff.

india has leveranged its manufacturing capacity to pre order 600 million dose of potential covid 19 vaccine and negotiating for another billion dose says a new global analysis of advance market commitments AMC for vaccine condidates against the coronavirus.

the total number of these vaccine dose if they are approved to be utilised in the course of time should be enough to vaccine half of the country over 1.3 billion population.

indian prime minister narendra modi will launch india covid-19 inoculation drive on16 january -2021 will interact with some of the healthcare workers who will be receiving the shots on day 1 the union health ministry said on Thursday.

less then 2 days before india start its nationwide inoculation drive ,about 95%of 1.1 crore covishield vaccine dose purchased by the government have been delivered across the country and the remaining 1 lakh vials will be delivered shortly ,sources told PTI .the first consignment of oxford astrazeneca’s covishield vaccine was dispatched from pune early Tuesday.

covid-19vaccine van:

vaccine van covid-19

We will utilize GPS-enabled thermal sensors with a control tower that will track the location and temperature of each vaccine shipment across their pre-set routes, 24 hours a day, seven days a week. These GPS-enabled devices will allow Pfizer to proactively prevent unwanted deviations and act before they happen.

vaccine site given;

covid-19 vaccine position

Female or male fewer than 130 lbs 22–25 5/8 –1″ Deltoid muscle of arm
Female or male 130–152 lbs 22–25 1″ Deltoid muscle of arm
Female 152–200 lbs 22–25 1–11/2″ Deltoid muscle of arm
Male 153–260 lbs 22–25 1–11/2″ Deltoid muscle of arm
Female 200+ lbs 22–25 11/2″ Deltoid muscle of arm
Male 260+ lbs 22–25 11/2″ Deltoid muscle of arm

Covid vaccine temprature in refrigerator;

Once a POU receives a thermal shipper with our vaccine, they have three options for storage:

  • Ultra-low-temperature freezers, which are commercially available and can extend shelf life for up to six months.
  • The Pfizer thermal shippers, in which doses will arrive, that can be used as temporary storage units by refilling with dry ice every five days for up to 30 days of storage.
  • Refrigeration units that are commonly available in hospitals. The vaccine can be stored for five days at refrigerated 2-8°C conditions.
    After storage for up to 30 days in the Pfizer thermal shipper, vaccination centers can transfer the vials to 2-8°C storage conditions for an additional five days, for a total of up to 35 days. Once thawed and stored under 2-8°C conditions, the vials cannot be re-frozen or stored under frozen conditions.
covid-19 refrigerator:

Procedure
1)Assess persons 16 years of age and older for
vaccination with Pfizer-BioNTech COVID-19 Vaccine
based on the following criteria:
2)No complete 2-dose COVID-19 vaccination
history, regardless of brand. If 2 doses of
a same-brand or mixed-brand series have
been administered, no additional doses are
recommended.
3)If the recipient has received 1 previous dose of
Pfizer-BioNTech COVID-19 Vaccine, the second
dose of the same brand should be administered.
4)This vaccine is administered in a 2-dose series.
Separate doses by at least 21 days.
5)Pfizer-BioNTech COVID-19 Vaccine should not be
administered at the same time as other vaccines.
Separate Pfizer-BioNTech COVID-19 Vaccine
from other vaccines by 14 days before or after
the administration of Pfizer-BioNTech COVID-19
Vaccine.
6) Pfizer-BioNTech COVID-19 Vaccine should be
deferred for at least 90 days for persons who
received passive antibody therapy.

Contraindications:
1)Severe allergic reaction (e.g., anaphylaxis) to a previous dose or
component of
either mRNA COVID-19 vaccine
2) Immediate allergic reaction± of any severity to a previous dose or
component of an mRNA COVID-19 vaccine (including polyethylene
glycol of vaccine components on
3) Immediate allergic reaction of any severity to polysorbate (due
to potential cross-reactive hypersensitivity with the vaccine.

Precautions:
1) History of an immediate allergic reaction to any other vaccine or
injectable therapy (i.e., intramuscular, intravenous, or subcutaneous
vaccines or therapies not related to a component of mRNA
COVID-19 vaccines or polysorbate)
2) Moderate to severe acute illness
3)Provide all recipients with a copy of the current federal Emergency Use
Authorization (EUA) Fact Sheet for Recipients and Caregivers.
4)Prepare to administer the vaccine.
5Choose the correct needle gauge, needle length, and injection site for
persons:
6) 16 through 18 years of age: 1-inch needle is recommended.
7) 19 years of age and older:

Covid-19 vaccine composition

mRNA Nucleoside-modified mRNA encoding the viral spike
(S) glycoprotein of SARS-CoV-2
Nucleoside-modified mRNA encoding the viral spike
(S) glycoprotein of SARS-CoV-2
Lipids
2[(polyethylene glycol)-2000]-N,
N-ditetradecylacetamide
PEG2000-DMG: 1, 2-dimyristoyl-rac-glycerol,
methoxypolyethylene glycol
1,2-distearoyl-sn-glycero-3-phosphocholine 1,2-distearoyl-sn-glycero-3-phosphocholine
Cholesterol Cholesterol
(4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)
bis(2-hexyldecanoate)
SM-102: heptadecane-9-yl 8-((2-hydroxyethyl)
(6-oxo-6-(undecyloxy) hexyl) amino) octanoate
Salts,
sugars,
buffers
Potassium chloride Tromethamine
Monobasic potassium phosphate Tromethamine hydrochloride
Sodium chloride Acetic acid
Dibasic sodium phosphate dihydrate Sodium acetate
Sucrose Sucrose

LEAVE A REPLY

Please enter your comment!
Please enter your name here